AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Ya Zeng
Public Documents
1
January 17, 2023
Cost-effectiveness analysis of first-line nivolumab plus ipilimumab combination thera...
Zhaoyan Chen, Fangyuan Tian, Ya Zeng, et al.